Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

479.44 -12.94 (-2.63%)
Streaming Delayed Price Updated: 3:33 PM EDT, Mar 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Vertex Pharmaceuticals

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
64 65 Next >
News headline image
Cathie Wood Just Flagged The Start Of A Biotech Revolution: These 2 Stocks With 10x Potential Are Leading It ↗
Cathie Wood is bullish on biotech companies using gene sequencing, AI, and CRISPR tech to cure previously untreatable diseases. 
Via Benzinga
Topics Artificial Intelligence
News headline image
What's Driving the Market Sentiment Around Vertex Pharmaceuticals? ↗
 
Via Benzinga
News headline image
3 No-Brainer Healthcare Stocks to Buy in June ↗
Via The Motley Fool
News headline image
4 Monster Stocks to Buy and Hold for the Next Decade ↗
Via The Motley Fool
Topics Artificial Intelligence World Trade
News headline image
2 Top Stocks to Buy Right Now ↗
Via The Motley Fool
Topics Economy
News headline image
If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today ↗
 
Via Benzinga
News headline image
3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow ↗
Via The Motley Fool
Topics Economy Government Law Enforcement
News headline image
3 Top Growth Stocks to Buy in the Second Half of 2025 ↗
Via The Motley Fool
Topics Artificial Intelligence Government World Trade
News headline image
2 Monster Growth Stocks to Buy and Hold for 10 Years ↗
Via The Motley Fool
Topics Bankruptcy
News headline image
5 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030 ↗
Via The Motley Fool
Topics Economy Law Enforcement
News headline image
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 20 Years ↗
 
Via Benzinga
News headline image
CRISPR Therapeutics Stock Could Double Your Money, According to Wall Street. Is It Time to Buy? ↗
Via The Motley Fool
News headline image
VRTX Q1 Earnings Call: New Product Launches and Pipeline Progress Amid Revenue Miss
Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) missed Wall Street’s revenue expectations in Q1 CY2025 as sales rose 3% year on year to $2.77 billion. The company’s full-year revenue guidance of... 
Via StockStory
Topics Intellectual Property
News headline image
Warren Buffett Remains Optimistic About America. Here Are Top American Companies Worth Investing In. ↗
Via The Motley Fool
Topics Economy Government Supply Chain
News headline image
1 Large-Cap Stock to Target This Week and 2 to Question
Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for... 
Via StockStory
News headline image
$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
Best Biotech Stocks to Buy in 2025
Discover the best biotech stocks of 2025, including top performers like Vertex and Regeneron, driven by clinical breakthroughs and strong investor momentum. 
Via MarketBeat
Topics ETFs Economy Government
News headline image
2 Biotech Stocks That Are Screaming Buys in May ↗
Via The Motley Fool
News headline image
This Stock Just Dropped by 12% in 1 Day. History Says This Will Happen Next ↗
Via The Motley Fool
News headline image
S&P 500, Dow Jones Pharma Stocks Boomerang As Trump Threatens Drug-Price Reform ↗
It's still unclear how President Donald Trump plans to tie drug prices in the U.S. to international prices. 
Via Investor's Business Daily
Topics Government Stocks
News headline image
Wynn Resorts, Microsoft, Palantir And A Health Care Stock On CNBC's 'Final Trades' ↗
 
Via Benzinga
News headline image
Prediction: These 2 Stocks Will Outperform the Market in the Next Five Years ↗
Via The Motley Fool
News headline image
Eli Lilly, Affirm And Regeneron Are Among Top 12 Large-Cap Losers Last Week (May 5-May 9): Are The Others In Your Portfolio? ↗
The worst performing large-cap stocks last week: ARGENX, VRTX, SMMT, MMYT, REGN, RKT, BNTX, AFRM, FNF, LLY, AUR, DASH. Any in your portfolio? 
Via Benzinga
News headline image
My Favorite Tariff Safe-Haven Stock to Buy on the Dip ↗
Via The Motley Fool
Topics Government World Trade
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
4 No-Brainer Stocks to Buy Right Now ↗
Via The Motley Fool
News headline image
Unpacking Q1 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) In The Context Of Other Therapeutics Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how therapeutics stocks fared in Q1, starting with Vertex... 
Via StockStory
Topics Artificial Intelligence
News headline image
Top S&P500 movers in Wednesday's session ↗
Curious about the top performers within the S&P500 index one hour before the close of the markets on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive... 
Via Chartmill
News headline image
What's going on in today's session: S&P500 movers ↗
Stay informed about the performance of the S&P500 index in the middle of the day on Wednesday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
64 65 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.